China Sky One Medical, Inc. (CSKI)
OTOTC · Common · CUSIP 16941P102
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for CSKI and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
16941P102
Market Cap
Micro Cap · $2 Million
Business: Based in Harbin, China Sky One Medical, Inc. manufactures, markets and distributes branded Chinese medicine mainly for external use. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company (TDR), Harbin First Bio-Engineering Company Limited (First), Heilongjiang Tianlong Pharmaceutical, Inc. (Tian long) and Peng Lai Jin Chuang Company Pharmaceutical Company (Jin Chuang), the Company manufactures and distributes around 90 pharmaceutical products, including traditional Chinese medicines, western medicines, diagnostic kits and cosmetics. These products are made with different formulations, such as creams, ointments, powders, sprays, injections and medicated skin patches. Their Company’s leading products include Sumei Slim patch for weight loss, anti-hypertension patches for high blood pressure, compound camphor cream for treating dermatitis, and other drops and ointments. In China, the Kang Xi trademark is well known for high quality and value. The Company’s distribution network covers 22 provinces and 125 municipalities in the PRC. China Sky One Medical distributes its products through third party distributors and direct selling to approximately 4500 retail stores and hospitals. Additionally, they exports its products to over 20 countries and regions including the US, Germany, Denmark, Switzerland, Hungary, South Korea, Singapore, Australia, Malaysia, Taiwan, and Hong Kong.

Company Contact

CEO
Liu Yan Qing
CFO
Stanley Hao
Investor Relations
Crocker Coulson · 646-213-1915 · crocker.coulson@ccgir.com
SEC EDGAR Filings
View filings »